Zinc transport across an in vitro blood-brain barrier model

被引:0
|
作者
Bobilya, DJ
Guerin, JL
Rowe, DJ
机构
来源
关键词
blood-brain barrier; brain zinc homeostasis;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The influence of plasma zinc concentration on the rate of zinc transport into the brain was examined using an in vitro model of the blood-brain barrier. The model was constructed by culturing porcine brain capillary endothelial cells on porous membrane filters suspended between two chambers of fluid, representing the capillary lumen and the cerebrospinal fluid of the brain. A relatively narrow range of zinc concentrations (2-30 mu mol/L) was employed in order to examine the most physiologicarlly relevant situation, obtained by diluting the serum or adding ZnCl2. The results consistently found that the rate of zinc transport across the blood-brain barrier was similar (P >.05) between 10 and 26 mu mol zinc/L; the rate was slower (P <.05) at zinc concentrations below 7 mu mol/L and faster (P <.05) above 30 mu mol zinc/L. These results demonstrate that the blood-brain barrier is highly restrictive to zinc. Zinc enters the brain at a constant rate within the range of plasma zinc concentrations that occur in healthy individuals. Outside this range, zinc transport was significantly altered. The zinc transport process was highly selective for zinc, since none of the analogous minerals could effectively compete with it. The zinc transport process does not require energy, since metabolic inhibitors did not influence the transport rate. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:9 / 18
页数:10
相关论文
共 50 条
  • [1] An in vitro model for vitamin A transport across the human blood-brain barrier
    Est, Chandler B.
    Murphy, Regina M.
    ELIFE, 2023, 12
  • [2] Lysophospholipids transport across blood-brain barrier in an in vitro reconstruction model
    Tsukahara, Tamotsu
    Sasaki, Masanori
    Haniu, Hisao
    Matsuda, Yoshikazu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 676 : 91 - 96
  • [3] In vitro model for evaluating drug transport across the blood-brain barrier
    Cecchelli, R
    Dehouck, B
    Descamps, L
    Fenart, L
    Buée-Scherrer, V
    Duhem, C
    Lundquist, S
    Rentfel, M
    Torpier, G
    Dehouck, MP
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (2-3) : 165 - 178
  • [4] Transport of Arylsulfatase A across the Blood-Brain Barrier in Vitro
    Matthes, Frank
    Woelte, Philipp
    Boeckenhoff, Annika
    Huewel, Sabine
    Schulz, Mareike
    Hyden, Pia
    Fogh, Jens
    Gieselmann, Volkmar
    Galla, Hans-Joachim
    Matzner, Ulrich
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (20) : 17487 - 17494
  • [5] Transport of amentoflavone across the blood-brain barrier in vitro
    Gutmann, H
    Bruggisser, R
    Schaffner, W
    Bogman, K
    Botomino, A
    Drewe, J
    PLANTA MEDICA, 2002, 68 (09) : 804 - 807
  • [6] Transport of treosulfan and temozolomide across an in-vitro blood-brain barrier model
    Linz, Ute
    Hupert, Michelle
    Santiago-Schuebel, Beatrix
    Wien, Sascha
    Stab, Julia
    Wagner, Sylvia
    ANTI-CANCER DRUGS, 2015, 26 (07) : 728 - 736
  • [7] Transport Across the Blood-Brain Barrier
    Fu, Bingmei M.
    MOLECULAR, CELLULAR, AND TISSUE ENGINEERING OF THE VASCULAR SYSTEM, 2018, 1097 : 235 - 259
  • [8] Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier
    Chopineau, J
    Robert, S
    Fénart, L
    Cecchelli, R
    Lagoutte, B
    Paitier, S
    Dehouck, MP
    Domurado, D
    JOURNAL OF CONTROLLED RELEASE, 1998, 56 (1-3) : 231 - 237
  • [9] Effects of metabolic inhibitors and analogous minerals on the rat of zinc transport across an in vitro model of the blood-brain barrier (BBB).
    Guerin, JL
    Bobilya, DJ
    FASEB JOURNAL, 1996, 10 (03): : 3054 - 3054
  • [10] Atomistic Model of Solute Transport across the Blood-Brain Barrier
    Jorgensen, Christian
    Ulmschneider, Martin B.
    Searson, Peter C.
    ACS OMEGA, 2022, 7 (01): : 1100 - 1112